Antagonist

Results: 956



#Item
521PBTC-025 v1.0 Version Date: [removed]Protocol Abstract and Schema Phase I study of the Smoothened (SMO) antagonist GDC-0449 for recurrent or refractory medulloblastoma

PBTC-025 v1.0 Version Date: [removed]Protocol Abstract and Schema Phase I study of the Smoothened (SMO) antagonist GDC-0449 for recurrent or refractory medulloblastoma

Add to Reading List

Source URL: www.pbtc.org

Language: English - Date: 2009-02-17 14:38:02
522Fertility / Leuprorelin / TAP Pharmaceuticals / Gonadotropin-releasing hormone agonist / In vitro fertilisation / Fertility medication / Endometriosis / Assisted reproductive technology / Gonadotropin-releasing hormone antagonist / Fertility medicine / Human reproduction / Medicine

DOC Document

Add to Reading List

Source URL: www.humanebiotech.com

Language: English - Date: 2014-09-21 02:19:17
523P  harmacology gs_ASME_Book

P harmacology gs_ASME_Book

Add to Reading List

Source URL: www.nattc.org

Language: English - Date: 2008-05-14 10:27:54
524U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

Add to Reading List

Source URL: www.fda.gov

Language: English
525The Targeting Acute Congestion with Tolvaptan In Congestive Heart Failure Study TACTICS-HF Felker GM, Adams KF, Cole RT, Patel CB, Egnaczyk G, Mentz RJ, Fiuzat M, and O’Connor CM on behalf of the TACTICS Investigators

The Targeting Acute Congestion with Tolvaptan In Congestive Heart Failure Study TACTICS-HF Felker GM, Adams KF, Cole RT, Patel CB, Egnaczyk G, Mentz RJ, Fiuzat M, and O’Connor CM on behalf of the TACTICS Investigators

Add to Reading List

Source URL: www.hfsa.org

Language: English - Date: 2013-10-11 12:59:07
526Non-Classical Antihistamines

Non-Classical Antihistamines

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2013-07-12 14:25:53
527Oral Antiemetic Agents (except Cesamet and Emend) (See separate Summary Sheets for Cesamet and Emend Coverage Policies) Covered medications Dolasetron (Anzemet), Granisetron (Kytril, Granisol™ oral solution

Oral Antiemetic Agents (except Cesamet and Emend) (See separate Summary Sheets for Cesamet and Emend Coverage Policies) Covered medications Dolasetron (Anzemet), Granisetron (Kytril, Granisol™ oral solution

Add to Reading List

Source URL: statehealthplan.state.nc.us

Language: English - Date: 2013-10-03 14:58:45
528EPA www.epa.gov Use of Novel Assays to Screen Large Chemical Inventories for Functional Estrogen Receptor (ER) Activity Keith Houck1, Matt Martin1, Richard Judson1, Daniel Rotroff1, Jon Melnick2, Jane Lamedin2, John West

EPA www.epa.gov Use of Novel Assays to Screen Large Chemical Inventories for Functional Estrogen Receptor (ER) Activity Keith Houck1, Matt Martin1, Richard Judson1, Daniel Rotroff1, Jon Melnick2, Jane Lamedin2, John West

Add to Reading List

Source URL: www.epa.gov

Language: English - Date: 2013-04-10 16:29:24
529Network Model of the Estrogen Receptor Pathway: Integrating a Battery of In Vitro HTS Assays Richard Judson(1), Felicia Maria Magpantay(2), Vijay Chickarmane(3), Cymra Haskell(4), Nessy Tania(5), Jean Taylor(6), Daniel R

Network Model of the Estrogen Receptor Pathway: Integrating a Battery of In Vitro HTS Assays Richard Judson(1), Felicia Maria Magpantay(2), Vijay Chickarmane(3), Cymra Haskell(4), Nessy Tania(5), Jean Taylor(6), Daniel R

Add to Reading List

Source URL: www.epa.gov

Language: English - Date: 2013-04-10 16:29:19
530Mississippi Division Of Medicaid Preferred Drug List Changes PDL Changes Effective Date: August 1, 2014 The following changes will be made to the Preferred Drug List (PDL), effective August 1, 2014, pending recommendatio

Mississippi Division Of Medicaid Preferred Drug List Changes PDL Changes Effective Date: August 1, 2014 The following changes will be made to the Preferred Drug List (PDL), effective August 1, 2014, pending recommendatio

Add to Reading List

Source URL: www.medicaid.ms.gov

Language: English - Date: 2014-07-10 10:31:58